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Objective. To analyze a nationally representative sample of women for correlates of dual-contraceptive-method use. Materials and
Methods. We conducted an analysis of the National Survey of Family Growth, 2006–2008, a cross-sectional survey of reproductive-
aged women in the United States. Results. Dual method use was reported by 7.3% of the 5,178 women in the sample. Correlates of
higher rates of dual-contraceptive-method use included age younger than 36 years and nonmarried marital status. Lower rates of
dual method usewere observed forwomen with less than a high-school education and women without consistent health insurance
in the past year. Compared to women using oral contraceptives, use of the contraceptive injection or long-acting reversible
contraception was associated with lower dual-method use. Conclusions. The overall rate of dual-method use in the USA is low.
Future interventions to promote dual method use should target high-risk groups with modiﬁable risk factors.
1.Introduction
Sexually transmitted infections (STIs) and unintended preg-
nancy are important and costly public health issues. The
United States has an estimated incidence of 19 million cases
of STIs each year which incurs $15.9 billion in cost to the
health care system [1, 2] and unintended pregnancy rates
continue to hover at nearly 50% [3]. One proposed strategy
to reduce the risks of unintended pregnancy and STI is the
promotion of dual-contraceptive-method use. Dual-method
protection includes use of a highly eﬀective pregnancy pre-
vention in conjunction with a barrier (e.g., male condom).
The male condom is the most commonly used method of
sexually transmitted infection (STI) prevention, whereas the
oral contraceptive pill and female sterilization are the most
common methods of pregnancy prevention in the USA [4].
The burden of unintended pregnancy and STIs is greater
among younger and economically disadvantaged men and
women [3, 5]. While nearly all women report having used
birth control and most have used a condom [4], dual-
methoduseisrelativelyuncommon.AnanalysisoftheYouth
Risk Behavior Surveillance System (YRBS) noted 6.6% of
young women using oral contraceptives also used a condom
at last intercourse [6]. According to another study of the
YRBS, use of dual-contraceptive methods increased from
3.2% in 1991 to 7.2% in 2001 [7]. A more recent publication
reviewing data from the National Longitudinal Study of
Adolescent Health noted 14–25% of participants report
using dual methods at last intercourse [8].
Most of the previous research focused on adolescents or
other populations who carry greater risk of both unintended
pregnancy and STI acquisition than the general population.
Therefore, we sought to evaluate correlates of dual-method
use in a national sample of reproductive-aged women.
2.MaterialsandMethods
We examined data from the 2006–2008 National Survey
of Family Growth (NSFG). The NSFG is a cross-sectional
surveyconductedbytheNationalCenterforHealthStatistics
(NCHS) at the Centers for Disease Control and Prevention
and is a survey of family life, marriage and divorce,
pregnancy, infertility, use of contraception, and men’s and2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Contraceptive methods used in the last intercourse in past 12 months by nonpregnant females aged 15–44 years, N = 5178.
Method N (%)† Dual Single
Any method of contraception
Yes, dual 448 (7.3)
Yes, single 3341(68.0)
No 1389 (24.7)
Type of contraceptive method
Nonbarrier methods∗ 2694 (55.7) 448 (13.1) 2246 (86.9)
Pills 1125 (22.3) 280 (21.7) 845 (78.3)
Sterilization/partner sterilization 1004 (24.1) 78 (4.4) 926 (95.6)
Injectables (Lunelle/Depo-Provera) 211 (2.8) 47 (16.7) 164 (83.3)
LARC 229 (4.6) 16 (3.3) 213 (96.7)
Patch 55 (0.6) 7 (16.0) 48 (84.0)
Ring 100 (2.1) 22 (32.6) 78 (67.4)
Barrier methods 1543 (26.8) 448 (27.1) 1095 (72.9)
∗Individual methods do not sum to % of Nonbarrier methods as respondents may have reported >1 Nonbarrier method at last intercourse.
†Weighted percent.
women’s health [9, 10]. The survey is a national probability
sample of individuals living in households and oversamples
Blacks, Hispanics, teens, and females. The NSFG was con-
ducted from 2006 to 2010 with 110 areas (primary sampling
units) selected. Each year a nationally representative sub-
sample of areas was interviewed. Interviews were conducted
by the University of Michigan’s Institute for Social Research
by trained female professional interviewers in the homes of
participants using computer-assisted personal interviewing.
Interviews lasted on average 80 minutes.
There were 7,356 women between the ages of 15 and 44
years of age interviewed between July 2006 and December
2008. Our analysis included 5,178 women who represent
the experiences of approximately 44.5 million women in
the United States. We excluded women who were currently
pregnant, have had a hysterectomy, had no sexual partners,
or reported only female sex partners and therefore not at
risk of unintended pregnancy (see Figure 1). We determined
currentcontraceptivemethodbasedonrespondents’answers
to a single question regarding “contraception method used
at last intercourse in the past 12 months [11]”. Respondents
could provide up to four methods in response to this
question allowing for estimation of dual-method use.
We calculated the prevalence of dual-method contra-
ceptive use and evaluated demographic and reproductive
characteristics that might be associated with dual-method
use. Potential predictors of dual-method use included age
group (15–20, 21–25, 26–30, 31–35, 36–40, 41–44 years),
gravidity, marital status (married, living with partner, wid-
owed/divorced/separated, never married), race (black, white,
other), Hispanic ethnicity, highest level of education (less
than high school, high school, some college, or college
graduate), continuous insurance coverage for all of the prior
12 months, and number of lifetime and past year sexual
partners.
In order to focus on correlates of dual-method use we
used all respondents who did not report dual-method use
7,356 women
5,178 women
Pregnant N = 336
Hysterectomy N = 163
No sexual intercourse N = 1.026
No opposite sex partners N = 653
Figure 1: National Survey of Family Growth (2006–2008) Analytic
Sample.
(including single-method users and respondents using no
method) as the referent. After evaluating univariate asso-
ciations using logistic regression, we used a multivariable
logistic regression model to assess independent predictors
of dual-method use. Our model included the factors found
to be associated with dual-method use in the univariate
analysis. Reference groups for the multivariable regression
were chosen by lowest rate of dual-method use, by clinical
judgment or the category with the largest number of
respondents.
For our examination of the association between primary
method of contraception and dual-method use, we com-
pared dual-method use to single-method use and excluded
those participants not using a primary contraceptive method
(n = 1,389) or using barrier only method (n = 1095), as
these women were not eligible for the outcome of interest.
“Pill users” included combination and progestin-only oral
contraceptives. Users of the transdermal contraceptive patchInfectious Diseases in Obstetrics and Gynecology 3
Table 2: Summary of participants’ characteristics by number of methods used.
All non-pregnant women
15–44 years (N = 5178)
Dual
(N = 448)
Single
(N = 3341)
None
(N = 1389) P value
Age <0.0001
15–20 731 (11.7) 134 (22.8) 438 (56.9) 159 (20.3)
21–25 976 (16.6) 124 (12.0) 595 (63.4) 257 (24.6)
26–30 1114 (18.4) 79 (5.1) 735 (65.9) 300 (28.9)
31–35 923 (18.5) 62 (5.2) 598 (67.5) 263 (27.2)
36–40 853 (19.5) 32 (1.8) 565 (73.1) 256 (25.1)
41–44 581 (15.2) 17 (2.3) 410 (77.9) 154 (19.8)
Race <0.0001
Black 1111 (15.1) 122 (9.4) 662 (61.6) 327 (29.0)
White 3499 (73.6) 301 (7.4) 2320 (69.8) 878 (22.7)
Others 568 (11.3) 25 (3.3) 359 (64.5) 184 (32.2)
Ethnicity 0.0049
Hispanic 1124 (16.5) 63 (4.2) 724 (66.1) 337 (29.7)
Non Hispanic 4054 (83.5) 385 (7.9) 2617 (68.4) 1052 (23.8)
Education 0.0003
Less than HS 1088 (17.1) 96 (6.7) 672 (61.1) 320 (32.2)
High School 1388 (25.8) 116 (7.2) 860 (67.0) 412 (25.9)
Some College 1123 (20.9) 125 (12) 724 (66.5) 274 (21.5)
College Graduate 1579 (36.2) 111 (4.9) 1085 (72.9) 383 (22.2)
Marital Status <0.0001
Married 2181 (53.3) 47 (1.6) 1461 (72.4) 673 (26.0)
Living with Partner 693 (13.2) 37 (6.1) 448 (64.4) 208 (29.5)
Widowed/Divorced/Separated 520 (8.0) 63 (9.8) 319 (63.3) 138 (26.9)
Never Married 1784 (25.5) 301 (18.9) 1113 (62.2) 370 (18.9)
Gravidity <0.0001
0 1539 (28.4) 240 (16.0) 959 (63.8) 340 (20.2)
1-2 1973 (37) 116 (4.3) 1271 (69.0) 586 (26.7)
3+ 1666 (34.6) 92 (3.3) 1111 (70.4) 463 (26.4)
Health insurance in the last 12 months <0.0001
Insured continuously 3630 (71.2) 345 (8) 2385 (70.1) 900 (21.9)
Uninsured at some time 1535 (28.8) 103 (5.6) 947 (62.4) 485 (32)
# Lifetime Sexual Partners 0.0008
1 1109 (24.3) 64 (4.9) 764 (72.4) 281 (22.7)
2-3 1165 (22.9) 110 (9.4) 750 (68.5) 305 (22.1)
4–9 1851 (34.5) 179 (7.7) 1196 (67.9) 476 (24.5)
10 or more 1053 (18.3) 95 (7.0) 631 (61.6) 327 (31.3)
# Sexual Partners in last 12 months 0.0045
1 4316 (86.9) 302 (5.8) 2829 (69.1) 1185 (25.1)
2 529 (8.2) 94 (18.9) 322 (58.6) 113 (22.5)
3+ 333 (4.9) 52 (13.8) 190 (63.5) 91 (22.7)
Desires pregnancy in the future <0.0001
Yes 3153 (55.9) 321 (10.1) 1852 (59.0) 980 (30.9)
No 1892 (41.3) 118 (3.8) 1396 (79.1) 378 (17.1)4 Infectious Diseases in Obstetrics and Gynecology
Table 3: Crude and adjusted odds ratios (and 95% conﬁdence
intervals) for dual versus non-dual-method use.
Crude Adjusted
Age
15–20 16.3 (9.38–28.5) 7.01 (3.19–15.4)
21–25 7.40 (3.68–14.9) 3.93 (1.90–8.10)
26–30 2.94 (1.69–5.11) 2.36 (1.29–4.31)
31–35 3.04 (1.61–5.74) 3.14 (1.72–5.76)
36–40 Referent Referent
41–44 1.27 (0.55–2.94) 1.33 (0.57–3.10)
Race
Black 1.30 (0.87–1.93) 0.97 (0.66–1.44)
White Referent Referent
Others 0.43 (0.26–0.72) 0.43 (0.25–0.75)
Ethnicity
Hispanic 0.52 (0.34–0.79) 0.73 (0.48–1.13)
Non Hispanic Referent Referent
Education
Less than HS 1.41 (0.94–2.11) 0.47 (0.27–0.81)
High school 1.49
(0.94−2.37)
0.94 (0.55–1.58)
Some college 2.61 (1.69–4.02) 1.07 (0.73–1.57)
College graduate Referent Referent
Marital status
Married Referent Referent
Living with partner 3.83 (2.08–7.04) 2.87 (1.62–5.07)
Widowed/divorced/
separated 6.45 (3.40–12.3) 7.86 (4.05–15.3)
Never married 13.9 (9.32–20.8) 6.45 (3.62–11.5)
Gravidity
0 5.58 (3.35–9.28) 1.46 (0.78–2.74)
1-2 1.31 (0.81–2.10) 0.85 (0.50–1.44)
3+ Referent Referent
Insurance in last 12 month
Insured continuously Referent Referent
Uninsured at some time 0.68 (0.48–0.95) 0.65 (0.47–0.90)
# Lifetime sexual partners
1 Referent Referent
2-3 1.96 (1.24–3.10) 1.50 (0.92–2.45)
4–9 1.57 (1.11–2.21) 1.22 (0.82–1.81)
10 or more 1.44 (0.88–2.36) 1.17 (0.72–1.91)
Sexual partner in last 12
months
1 Referent Referent
2 3.85 (2.58–5.76) 1.29 (0.87–1.90)
3+ 2.57 (1.60–4.14) 0.81 (0.48–1.36)
Desires pregnancy in future
Yes 2.82 (1.93–4.13) 0.98 (0.60–1.58)
No Referent Referent
and those who relied on the contraceptive vaginal ring were
groupedtogetherduetosmallnumbersineachcontraceptive
subgroup. Participants who used either of the injectable
contraceptives such as depot medroxyprogesterone acetate
(DMPA) or combination injectable contraceptives were
grouped together as “injectables.” Women who used either
an intrauterine device (IUD) or the contraceptive implant
were grouped together as users of long-acting reversible
contraceptives (LARCs). And ﬁnally, those who relied on
eitherfemaleormalesterilizationaregroupedtogetherinthe
“sterilization group.” In cases where respondents reported
more than one contraceptive method, we chose the most
eﬀective method as deﬁned by Trussell [12] as the primary
contraceptive method. We then used this variable as a
covariate in an independent multivariable logistic regression
to evaluate the impact of primary method on dual-method
use. All analyses were conducted in SAS (v. 9.2, SAS Institute,
Cary, NC).
3. Results
An estimated 7.3% of US women reported dual-method
use at their last intercourse in the last 12 months in the
2006–2008 NSFG. Over two-thirds of women reported a
single–method of contraception and one-quarter reported
no method used at the last intercourse (see Table 1). Ring
users were most likely to report dual-method use with
32.6% dual use at last intercourse, whereas 21.7% of pill
users, 16.7% of injectable users, and 16.0% of patch users
reported dual-method use at last intercourse. Those relying
on sterilization (4.4%) or currently using a LARC method
(3.3%) were less likely to report dual-method use than
women relying on less eﬀective non-barrier contraceptive
methods.
We examined the frequency of dual- and single-method
use across demographic and clinical characteristics and
found that rates of method use varied by age, race, ethnicity,
education, marital status, pregnancy history, insurance sta-
tus, and number of sexual partners (lifetime and past year;
see Table 2). In particular, young women (15–20 years) who
are at highest risk of both STI and unintended pregnancy
reported the highest rates of dual-method use (22.8%).
African American women had higher rates of dual-method
use (9.4%) compared with Caucasian or Hispanic women.
Education was associated with rates of dual-method use
with the highest levels among women with some college
education (12.0%). Never married women were most likely
to report dual-method use (18.9%), as were nulligravid
women (16.0%). Continuously insured women were more
likely to report dual-method use (8.0%) than those with
some period of no insurance (5.6%). Dual-method use
was associated with sexual history (number of lifetime sex
partners or in the past year) in the unadjusted analyses.
We also examined the impact of future pregnancy intention
on dual-method use. We found that women who “want
a pregnancy at some time” were more likely to use dual-
method protection in our unadjusted analyses.
Results of our logistic regression model are shown in
Table 3. Potential confounders identiﬁed in the univariateInfectious Diseases in Obstetrics and Gynecology 5
Table 4: Association of primary contraceptive method with dual-
method use.
Primary contraceptive method Crude Adjusted
Pills Referent Referent
Patch/ring 1.40 (0.68–2.89) 1.15 (0.61–2.19)
Injectables (Lunelle/DMPA) 0.73 (0.44–1.23) 0.49 (0.28–0.85)
LARC 0.12 (0.06–0.24) 0.30 (0.14–0.63)
Sterilization 0.16 (0.10–0.25) 0.69 (0.39–1.22)
Note: controlled for age, race, ethnicity, level of education, marital status,
gravidity, insurance status in the last 12 months, lifetime number of sexual
partners, number of sexual partners in the last 12 months, and pregnancy
intention.
analyses included age, race, ethnicity, level of education,
marital status, gravidity, insurance status in the last 12
months, lifetime number of sexual partners, number of
sexual partners in the last 12 months, and desire for future
pregnancy. Women under the age of 36 were signiﬁcantly
more likely to report dual-method use compared to women
in the 36–40 years age group. When compared to married
women, never married women (ORadj 6.5, 95% CI 3.6–11.5)
and those who were widowed/divorced/separated (ORadj 7.9,
95% CI 4.1–15.3) had the highest likelihood of dual-method
use. Lack of insurance coverage during the prior year was
associated with lower rates of dual-method use (ORadj 0.7,
95% CI 0.5–0.9) compared to women who had continuous
coverage. While desire for future childbearing was associated
with dual use in our bivariate analysis (OR = 2.8, 95% CI
1.9–4.1),itwasnolongersigniﬁcantinourlogisticregression
model (ORadj = 1.0, 95% CI 0.6–1.6).
Since age and education are closely linked, we examined
the results of the logistic regression model with and without
age and education. Estimates of eﬀe c tf o ra g ew e r el a r g e l y
unchanged by excluding education with the exception of the
youngest category of women (15–20 year-olds) which was
modestly attenuated.
Finally, we used a logistic regression model to examine
the relationship of dual-method use by primary method
of pregnancy prevention with pill users as the referent
group, since pill use was the most common primary
method reported (Table 4). After adjusting for all the factors
associated with dual-method use from the prior adjusted
analysis, women who relied on the contraceptive injection
were less likely to report additional barrier use (ORadj 0.5,
95% CI 0.3–0.9). LARC users were signiﬁcantly less likely to
report dual-method use (ORadj 0.3, 95% CI 0.1–0.6). There
was no statistically signiﬁcant diﬀerence in the likelihood of
dual use in male or female sterilization and patch/ring users
compared to pill users.
4. Discussion
Our analysis indicated 7.3% of reproductive-aged women
at risk for both pregnancy and STIs in this nationally rep-
resentative sample reported using dual-method protection
at last intercourse. Increased dual-method contraceptive use
was associated with younger age and not being married,
but inversely associated with gaps in insurance coverage. A
statistically signiﬁcant lower rate of dual-method use was
noted in women relying on the most eﬀective forms of
reversiblepregnancyprevention:DMPAandLARCmethods.
The 7.3% overall rate of dual-method use among the
whole sample is consistent with previously published reports
[6, 7]. It is encouraging to note the higher rate of dual-
method use among teenagers and those under age 25 in
this analysis as they have the highest incidence of STIs and
unintended pregnancy. Sieving et al. noted a higher rate of
two methods of contraception being used at most recent
intercourse among older teens versus younger teens [8]. We
found 22.8% of 15–20-year olds and 12% of 21–25-year olds
reported dual-method protection. In a sample of women
using LARC methods, Pazol et al. noted that high-school
graduates were more likely than those without a high-school
diplomatoreportcondomuseatlastintercourse[13].Thisis
alsoconsistentwithourﬁndingthathighereducationallevels
are associated with dual-method use.
Few studies have evaluated factors associated with dual-
method use. One study of adolescent girls noted that the
strongest correlate of dual-method use was a desire to avoid
pregnancy [14]. Impulsivity, self-esteem, social support,
relationship status, partner communication, fear of condom
negotiation, and desire to avoid unintended pregnancy have
been associated with dual-method use among adolescents
[14, 15].
Our ﬁnding of a positive association of dual-method
use among respondents who are not currently married
compared to married women is not surprising. Married
women likely perceive less risk of STI acquisition and
unintended pregnancy. This is consistent with other reports
oflowerratesofcondomuseamongmarriedwomen[4].The
lower rate of dual-method use reported among women who
had a gap in insurance coverage during the past 12 months
is likely due to limited access to prescription contraceptive
methods or interruptions in continuity of care during these
periods [16].
There is concern that women relying on LARC methods
may have lower rates of barrier method use. Pazol et al.
examined NSFG data from 2002-2003 and found that only
1.9% (95% CI 0.0–4.0) of respondents who reported using
LARC methods also used a condom at last intercourse [13].
Our analysis also noted lower rates of dual-method use in
women using LARC methods and DMPA. This lower rate
may be due to these women feeling reassured that they have
ah i g h l ye ﬀective contraceptive method and not recognizing
their continued risk of STI acquisition.
A major strength of our study is that this data represents
a national sample of reproductive-aged which reﬂects the
experiences of approximately 44.5 million women in the
United States. Our ﬁndings are more generalizable than
studies that focus on adolescents or clinic-based samples.
Our sample size provided suﬃciently large numbers to
assess diﬀerences in dual-method use across many exposure
categories. However, there are some limitations of this
analysis.Ourestimateof7%dual-methodusemaybeaslight
underestimate, as there are some women in the denominator
of this analysis that may not be using dual methods or any6 Infectious Diseases in Obstetrics and Gynecology
contraception due to a desire to conceive. Data regarding
current contraceptive method was based on the respondents’
reports of contraception at last intercourse which may be
aﬀected by both diﬃculty with recall and social desirability
issues.Itisdiﬃculttoextrapolatedual-methodcontraceptive
use at last intercourse to dual use as a regularly practiced
behavior. Additionally, the low number of women reporting
using LARC, the patch, or ring for contraception reduces
the level of precision of our estimates and makes it diﬃcult
to draw conclusions regarding women using these methods.
Ideally, we would have liked to have examined other markers
of high-risk sexual activity, such as a history of abortion
or sexually transmitted infection, but we were limited by
questions included in the NSFG survey and underreporting
of abortions [17].
5. Conclusions
A small proportion of women who are at risk for unin-
tended pregnancy and STIs use dual-method protection.
We believe the ﬁndings from this study can be used to
inform interventions to improve dual-method use. It is our
hope that there will be increased access to prescription
contraceptive methods due to the Department of Health
and Human Services recommendations for contraceptive
coverage [18]. This could alleviate the gaps in insurance
coverage which we found to be associated with decreased
rates of dual-method use. Our ﬁndings of the lowest rates
of barrier use among users of the most eﬀective reversible
contraceptives (LARC methods and DMPA) suggest that
women using these methods are an important group for
intervention development to promote dual-method use. A
comprehensive approach to educating women about risk
factors for unintended pregnancy and STI acquisition along
with methods of prevention is essential.
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